Shared Decision-Making in Treatment Selection in Multiple Myeloma in Spain: The PRISMMA Study.

ABSTRACT:

Introduction

Perceptions and experiences of shared decision-making between patients and physicians in multiple myeloma (MM) care are not fully understood. A survey study was conducted to explore these perspectives in Spain.

Methods

Two anonymous online surveys, one for haematologists and one for MM patients, were developed. Both included related questions on treatment goals, treatment options discussion and the decision-making process.

Results

In total, 72 haematologists and 76 MM patients completed the survey, including 23 in first-line treatment, 37 in second-line or later and 16 with no or unknown treatment line. The most common treatment goal for patients (67%) and haematologists (90%) was to prolong survival with a good quality of life. Becoming symptom-free was

SUBMITTER: Cabanas V 

PROVIDER: S-EPMC12781151 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature